02:26:46 EDT Tue 12 May 2026
Enter Symbol
or Name
USA
CA



Mindbio Therapeutics Corp (2)
Symbol MBIO
Shares Issued 7,283,063
Close 2026-05-11 C$ 1.05
Market Cap C$ 7,647,216
Recent Sedar+ Documents

Mindbio develops fatigue module add-on for Edge AI

2026-05-11 19:16 ET - News Release

Mr. Justin Hanka reports

MINDBIO DEVELOPS FATIGUE PREDICTION MODEL USING SPEECH ANALYTICS AND AI

Mindbio Therapeutics Corp. has developed a fatigue recognition and detection technology using an analysis of voice and the company's proprietary AI (artificial intelligence). The fatigue module will be added to the company's Edge AI intoxication detection kiosks as an add-on commercial feature designed to predict and detect fatigue in high-risk industries, such as aviation, road transport and mining, where sobriety and alertness is paramount to safety.

In a world-first claim by the company, in its recent patent application, titled "Detection of Neurologically Active Substances and Fatigue in a Human by Analysis of Voice Characteristics," the technology aims to predict intoxication from a range of substances plus fatigue, in an add-on to the company's anticipated commercial offering, which is on track for initial commercial testing in late Q2 2026. The technology processes human voice audio signals using a short sentence or pangram to identify an individual potentially affected by a neurologically active substance or by fatigue.

The company's chief executive officer Justin Hanka said: "The digital health diagnostics market represents a significant opportunity for Mindbio to leverage its non-invasive diagnostics technology with a first mover advantage in the detection of neurologically active substances and now fatigue from voice and AI. The company has claimed 15 world firsts in its recent patent application filing and is progressing towards commercialization with the development of its Edge AI intoxication and fatigue detection kiosks."

About Mindbio Therapeutics Corp.

Mindbio is a biotechnology company that is commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments, including the mining industry, aviation, construction and law enforcement.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.